Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| argenx SEADR(ARGX) | 92,500 | 115,000 | +22,500 | $56.89M | $68.06M | 37.34% | +$11.18M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 727,982 | 907,240 | +179,258 | $40.75M | $48.06M | 26.37% | +$7.30M |
| Revolution Medicines, Inc.(RVMD) | 210,000 | 392,011 | +182,011 | $9.19M | $13.86M | 7.61% | +$4.68M |
| Soleno Therapeutics Inc | 70,027 | 172,902 | +102,875 | $3.15M | $12.35M | 6.78% | +$9.21M |
| Disc Medicine, Inc.(IRON) | 185,000 | 243,311 | +58,311 | $11.73M | $12.08M | 6.63% | +$349.0K |
| Protagonist Therapeutics Inc | 0 | 175,184 | +175,184 | $0 | $8.47M | 4.65% | +$8.47M |
| Stoke Therapeutics, Inc.(STOK) | 305,387 | 730,717 | +425,330 | $3.37M | $4.86M | 2.67% | +$1.49M |
| Septerna, Inc.(SEPN) | 0 | 824,878 | +824,878 | $0 | $4.78M | 2.62% | +$4.78M |
| Kymera Therapeutics, Inc.(KYMR) | 77,535 | 136,605 | +59,070 | $3.12M | $3.74M | 2.05% | +$619.6K |
| TScan Therapeutics, Inc.(TCRX) | 1,755,987 | 2,017,650 | +261,663 | $5.34M | $2.78M | 1.53% | -$2.55M |
| Cidara Therapeutics Inc | 196,949 | 104,380 | -92,569 | $5.11M | $2.25M | 1.23% | -$2.87M |
| Corcept Therapeutics Incorporated(CORT) | 0 | 5,000 | +5,000 | $0 | $571.1K | 0.31% | +$571.1K |
| Immunocore Holdings plcADS(IMCR) | 0 | 9,011 | +9,011 | $0 | $267.4K | 0.15% | +$267.4K |
| Rapt Therapeutics Inc | 0 | 109,830 | +109,830 | $0 | $134.0K | 0.07% | +$134.0K |
| Atyr Pharma Inc | 432,561 | 0 | -432,561 | $1.57M | $0 | — | -$1.57M |
| Avadel Pharmaceuticals Plc | 1,004,790 | 0 | -1,004,790 | $10.56M | $0 | — | -$10.56M |
| Axsome Therapeutics, Inc.(AXSM) | 174,769 | 0 | -174,769 | $14.79M | $0 | — | -$14.79M |
| Cytokinetics, Incorporated(CYTK) | 20,000 | 0 | -20,000 | $940.8K | $0 | — | -$940.8K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 2,274,157 | 0 | -2,274,157 | $18.47M | $0 | — | -$18.47M |
| Pliant Therapeutics, Inc.(PLRX) | 535,494 | 0 | -535,494 | $7.05M | $0 | — | -$7.05M |
| Trevi Therapeutics, Inc.(TRVI) | 1,084,135 | 0 | -1,084,135 | $4.47M | $0 | — | -$4.47M |